Abstract
Liver transplantation and antiviral treatments for hepatitis have improved the outlook for many patients with liver disease. For patients with cirrhosis, new developments herald targeted treatments
Publication types
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Biomarkers / blood
-
Cytokines / physiology
-
Humans
-
Hypertension, Portal / etiology
-
Hypertension, Portal / prevention & control
-
Liver Cirrhosis / etiology
-
Liver Cirrhosis / pathology
-
Liver Cirrhosis / therapy*
-
Matrix Metalloproteinases / metabolism
-
Recovery of Function
-
Tissue Inhibitor of Metalloproteinases / metabolism
Substances
-
Biomarkers
-
Cytokines
-
Tissue Inhibitor of Metalloproteinases
-
Matrix Metalloproteinases